Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Anika Therapeutics to Present at Sidoti & Company Ninth Annual Emerging Growth Institutional Investor Forum.


WOBURN, Mass. -- Anika Therapeutics, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ANIK) today said that Chief Executive Officer Charles H. Sherwood, Ph.D., will present at the Sidoti & Company Ninth Annual Emerging Growth Institutional Investor Forum on Wednesday, April 6, 2005 at 4:30 p.m. EST at The Grand Hyatt hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
. Dr. Sherwood will present an overview of the company and discuss current products, product pipeline, growth drivers and recent financial performance. Some of the information to be presented by Dr. Sherwood may contain information that has not been previously disclosed.

About Anika Therapeutics, Inc.

Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function.  polymer found throughout the body. Anika products include OrthoVisc(R), a treatment for osteoarthritis of the knee available internationally and marketed in the U.S. by Ortho Biotech Products, L.P., and Hyvisc(R), a treatment for equine osteoarthritis marketed in the U.S. by Boehringer Ingelheim Vetmedica, Inc. Anika manufactures Amvisc(TM) and Amvisc Plus(TM), HA viscoelastic Adj. 1. viscoelastic - having viscous as well as elastic properties
natural philosophy, physics - the science of matter and energy and their interactions; "his favorite subject was physics"
 products for ophthalmic surgery. It also produces CoEase(TM), which is marketed by Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. , Inc., STAARVISC(TM)-II distributed by STAAR Surgical Company and Shellgel(TM) for Cytosol cytosol /cy·to·sol/ (sit´ah-sol) the liquid medium of the cytoplasm, i.e., cytoplasm minus organelles and nonmembranous insoluble components.cytosol´ic

cy·to·sol
n.
 Ophthalmics, Inc.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 22, 2005
Words:230
Previous Article:Kensington Resources Ltd.: Higher Grade Diamond Results For Drillhole 04-140-052 From Fort A La Corne Kimberlite 140/141.
Next Article:Best Buy to Award D.C. Schools $250K for Using Interactive Technology to Enhance Education; Te@ch program encourages creative technology use in...
Topics:



Related Articles
Anika Therapeutics CEO, Charles Sherwood, to Present at Rodman & Renshaw Techvest Healthcare Conference; October 21 Presentation Accessible via the...
Anika Therapeutics to Present at MassMEDIC MedTech Investors Conference.
ArthroCare to Present During Sidoti & Co. Emerging Growth Institutional Investor Forum.
Invacare CFO Gregory C. Thompson Presenting at Sidoti Conference.
Anika Therapeutics to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference.
Anika Therapeutics to Present at Sidoti & Company Fourth Annual West Coast Emerging Growth Institutional Investor Forum.
Anika Therapeutics Announces Date for 2005 Fourth Quarter Results Conference Call.
Invacare CFO Gregory C. Thompson Presenting at Sidoti Conference.
Anika Therapeutics Retains Sharon Merrill Associates as Investor Relations Counsel; Boston-based IR Firm Implements Program to Generate Awareness of...
ArthroCare Corp. to Present During Sidoti & Company 4th Annual Palm Beach Emerging Growth Institutional Investor Forum.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles